Member Info for bunsenburner123

And it’s not from some dodgy gin pot organisation like ROQ are hoping to conclude. It’s from the Wallonia GOVERNMENT

GENF has received just over €14m in grant money

As a long term play - from sub 1p it’s an astonishing opportunity

You can thank the seller in the coming weeks and months

€4m non dilutive is essentially free money. And what’s even more credible is it’s from The Goverment of Wallonia - HUGE endorsement

Expect a few ups and downs before we really shift

Same as WCAP - seller at 0.8p. Seller cleared and jumped to 1p. The real gains were the week after when it hit 1.8p

RNS from two weeks ago or so

Should be out now I see that as a v positive RNS

Well done holders

Reminds me when MPL had the ex advisor to Trump from 2019!

As per my message below - I estimate c£20k left to be sold before we see a very large sell trade go through

It’s utter madness down here. The only listed longevity company in Europe - a serious player around the world in longevity. Valued at sub £3m when over £20m and years and years of scientific improvements etc have been made

It’s insane

We should be minimum valued at £20m

It’s the government that’s put £m’s literally millions upon millions into GENF

I’ve been looking into all this selling and the only conclusion I can come to is it’s either Premier Miton, Bauer or Beeston.

Let’s say worst case it’s all three - total 10.4%

That’s circa £280k

We’ve already had a trade of £125k I think it was

Leaves £155k. I’ve since taken £40k leaving just over £100k

Others have taken certainly over £50k as well, leaving £50k (especially after yesterday’s news, probably more)

The SP has dropped a fair bit since the £125k meaning they would have sold even more

My estimate is in the worst case scenario- there can’t be more than £20k left to sell

There’s no way it’s anyone else. It’s not rocket science guys - when this seller clears - this 🚀 north

GLA

That’s great Laura. But be prepared to have some patience

This a for me a super low risk play with high reward

We need the seller to clear and then I feel it’s a week to wait for rerating

Will be over 1p but will take a week of up 2 down 1 type stuff

1p is a joke. Only down here because of this distressed seller

Look at WCAP was .8p and wouldn’t budge even with loads of volume. Then out of nowhere popped to 1p

Then a week later 1.7p

When the seller clears will pop 20%. The real gain is waiting another week after that

And then another 6 months for 5x

Down 10% on game changing news

Insane. Just take advantage are my thoughts

I’ve been buying more. Once the seller has cleared this will rocket back

1.5p yes definitely

Clear this seller and you won’t be able to buy under 1p

We need the signal - no real signal yet.

We need it to go NT @ .65p. And then only a few buys and it’s NT again

Then it’s game on

Honestly I’ve never in all my years seen something so outrageously opposite to what should happen

We’ve just had genuinely game changing news, from a SP/mkt cap we should never have even been near

Yet we’re red

It’s so obvious - clear this damn overhang and this will rocket back on the tinniest of buy volume

Yup. It’s utterly crazy rn

Just have to be patient and wait for the seller to get out

In the meantime time I’ll be topping up

Great question

Honestly - no idea but can’t be much

CEO holds I think 35%

Maybe PM selling the rest of theirs

Who knows

Either way - when it’s cleared everyone will be buying in here

Absolute steal down here - cheapest it’s ever been

And yet we’ve received c€15m in non dilutive funding now it’s insane

Just need to clear the overhang and it properly shifts

Don’t know how much is left but when it clears it rockets

Literally priced to fail

Today’s news is EPIC

Only listed longevity company in THE WHOLE OF EUROPE

AVCT just raised money - the same amount of money but not NON DILUTIVE and their mkt cap is well over £100m

Genflow Biosciences (GENF) with a market cap of just £3 million and confirmed non-dilutive grant support of €4 million (~£3.4m) from the Wallonia Region is, on paper, trading below the value of its secured funding alone — without even factoring in its intellectual property, research programs, or listing status.

Key points:

• €4m non-dilutive grant = more than its entire market cap

• Program (GF-1002 for MASH) is continuing without interruption, meaning runway and momentum are intact.

• Valuation disconnect: Market seems to be pricing in high risk or ignoring the fundamental backing (likely due to poor liquidity, past comms, or investor fatigue).

• Niche focus (longevity / gene therapy) — tough to value, but highly scalable if it hits a milestone.

Bottom line:

This looks deeply undervalued from a risk/reward standpoint, especially if the company can show progress in trials or attract a strategic partner

Wow!

More than their mkt cap in cash and not from some dodgy finance company - From the government

1p for starters